Pernetrexed second-line treatment in malignant pleural mesothelioma following platinum-based first-line

被引：2
|
作者：
Sorensen, J. B.
Sundstrom, S.
Perell, K.
Thielsen, A.
机构：
[1] Natl Univ Hosp, Finsen Ctr, Copenhagen, Denmark
[2] St Olav Hosp, Trondheim, Norway
来源：
LUNG CANCER | 2006年 / 54卷
关键词：
D O I：
10.1016/S0169-5002(07)70268-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
192
引用
收藏
页码：S46 / S47
页数：2
相关论文
共 50 条
  • [41] Treatment of Malignant Pleural Mesothelioma Beyond First-Line Among Hispanics (MeSO-CLICaP)
    Corrales-Rodriguez, Luis
    Cardona, Andres F.
    Arrieta, Oscar
    Oblitas, George
    Rojas, Leonardo
    Bacon, Ludwing
    Martin, Claudio
    Wills, Beatriz
    Cuello, Mauricio
    Mass, Luis
    Vargas, Carless
    Carranza, Hernan
    Otero, Jorge
    Angelina Perez, Maria
    Gonzalez, Lisde
    Chirinos, Luis
    Rose, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) : S217 - S218
  • [42] Treatment of Malignant Pleural Mesothelioma beyond First-Line among Hispanics (MeSO-CLICaP)
    Corrales, Luis
    Cardona, Andres
    Arrieta, Oscar
    Oblitas, George
    Rojas, Leonardo
    Bacon, Ludwing
    Martin, Claudio
    Wills, Beatriz
    Cuello, Mauricio
    Mas Lopez, Luis Alberto
    Vargas, Carlos
    Carranza, Hernan
    Otero, Jorge
    Perez, Maria
    Gonzalez, Lisde
    Chirinos, Luis
    Archila, Pilar
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1373 - S1373
  • [43] Treatment of NSCLC Patients with Malignant Pleural Effusion Harboring Exon 19 and 21 EGFR Mutations after First-Line and Second-Line TKIs
    Zheng, Zhen
    Jin, Xiance
    Xie, Congying
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1245 - S1246
  • [44] Oral vinorelbine as a second-line chemotherapy option in advanced malignant pleural mesothelioma.
    Rosales, Raul Rogelio Trejo
    Cerrillo, Jose Gustavo Nunez
    Godinez, Juan Carlos Silva
    Sala, Rodrigo Fernando Riera
    Campos, Maritza Pena
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [45] Phase II study of sunitinib as second-line therapy in malignant pleural mesothelioma (MPM)
    Nowak, A. K.
    Millward, M. J.
    Francis, R.
    van der Schaaf, A.
    Musk, A. W.
    Byrne, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] A phase II single arm trial evaluating the efficacy and safety of Temozolomide for second-line treatment of neuroendocrine carcinomas progressing after first-line platinum-based therapy
    Cannella, L.
    von Arx, C.
    Bracigliano, A.
    Pizzolorusso, A.
    Antonella, D. S.
    Clemente, O.
    Modica, R.
    Di Marzo, M.
    Tatangelo, F.
    Tafuto, S.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 169 - 169
  • [47] Echo(cardiography) in a first-line and second-line approach
    Garretsen, JW
    TIJDSCHRIFT VOOR DIERGENEESKUNDE, 1998, 123 (20) : 592 - 593
  • [48] Establishment of a first-line second-line treatment model for human pulmonary adenocarcinoma
    Wang, Lining
    Wang, Yu
    Guan, Qi
    Liu, Yong
    He, Tianyi
    Wang, Jiaru
    ONCOLOGY LETTERS, 2016, 12 (06) : 4461 - 4466
  • [49] Gemcitabine and cisplatin: Second-line chemotherapy for malignant mesothelioma?
    Vogelzang, NJ
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) : 2626 - 2627
  • [50] Pemetrexed/cisplatin versus gemcitabine/cisplatin as first-line treatment for Egyptian patients with malignant pleural mesothelioma
    Alorabi, M. O.
    El Wakil, H. M.
    El-Mahdy, M. M.
    Salem, D. A.
    Essa, A. E.
    Gaballah, A. M.
    ANNALS OF ONCOLOGY, 2019, 30 : 752 - 752
12345